...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Just one more thought...I promise!
Reply New Message
Prev Message Back To Forum Threaded View Next Message

"Currently you're probably right but certainly not by the time it goes public."

At which time I expect to have 1/3 the number of shares in the public Newco that I currently have.

2 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply